Preclinical studies have revealed that TGF-β drives tumour cell migration and metastatic invasion [15, 16], cancer stem cell maintenance [17], chemoresistance [18, 19] and immunosuppression [20–23]. This evidence concerns the gene TGFB1 and neoplasm.